Hello All,
I'm just starting out my Due Diligence on this CVR. Sorry for the totally "newb" questions, but rather than go and re-invent the wheel, I wanted to ask you more knowledgable investors a few questions:
(1) Are we expecting FDA approval? At least prior to the expiration? (6 years post-merger)
(2) I saw a few posters excited about the revenue milestones, so that's why I was searching for any news about the approval question in (1) above. I took a quick look at the chart that dipped from $3.00 down to the 0.20's.. which suggested that I might have missed the boat on the FDA approval milestone.
I haven't seen anything on the web about FDA approval, which makes this a very interesting and compelling value play.
I'm also looking into CYHHZ, but that's more of a litigation CVR play and I'm somewhat jaded about Litigation tracking securities….
Anyway, thanks in advance for your patience and willingness to share information with a newcomer!
Very Best,
Jared